AMENDMENT NO. 1 TO SECURED CONVERTIBLE PROMISSORY NOTESecured Convertible Promissory Note • January 17th, 2024 • Abvc Biopharma, Inc. • Pharmaceutical preparations
Contract Type FiledJanuary 17th, 2024 Company IndustryThis Amendment No. 1 to Senior Convertible Promissory Note (this “Amendment”) is entered into as of January 12, 2024, by and between Lind Global fund II LP, a Delaware limited partnership (“Lender”), and ABVC BioPharma, Inc., a Nevada corporation (“Borrower”). Capitalized terms used in this Amendment without definition shall have the meanings given to them in the Note (as defined below).